Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Unicycive Therapeutics (UNCY) Inventory (2024 - 2026)

Unicycive Therapeutics filings provide 1 years of Inventory readings, the most recent being $3.6 million for Q4 2024.

  • On a quarterly basis, Inventory changed N/A to $3.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was $3.6 million, a N/A change, with the full-year FY2024 number at $3.6 million, changed N/A from a year prior.
  • Inventory hit $3.6 million in Q4 2024 for Unicycive Therapeutics.
  • In the past five years, Inventory ranged from a high of $3.6 million in Q4 2024 to a low of $3.6 million in Q4 2024.